Table 3.
Variable | n (number of events) | Survival, months, median (95% CI) | P-value |
---|---|---|---|
Age | |||
≤60 years | 33 (17) | 52 (32–73) | 0.330 |
>60 years | 48 (31) | 27 (5–50) | |
Gender | 0.586 | ||
Male | 39 (25) | 27 (2–52) | |
Female | 42 (23) | 46 (23–70) | |
Underlying liver disease | 0.131 | ||
None | 56 (37) | 31 (19–44) | |
Present | 25 (11) | 97 (26–168) | |
Number of tumours | |||
Single | 73 (42) | 41 (15–67) | 0.153 |
Multiple | 9 (7) | 27 (3–51) | |
Recurrence | |||
Yes | 51 (35) | 38 (23–54) | 0.193 |
No | 30 (13) | >median | |
Positive margin | |||
Yes | 19 (11) | 38 (6–70) | 0.850 |
No | 60 (35) | 41 (14–68) | |
Adjuvant treatment | |||
Yes | 23 (15) | 31 (16–36) | 0.241 |
No | 58 (33) | 46 (15–78) | |
Vascular invasion | |||
Yes | 42 (26) | 24 (17–30) | 0.020 |
No | 38 (22) | 57 (19–96) | |
Satellites | |||
Yes | 20 (12) | 24 (18–30) | 0.028 |
No | 60 (35) | 52 (30–74) | |
Perineural invasion | |||
Yes | 21 (15) | 20 (12–27) | 0.001a |
No | 60 (33) | 55 (35–76) | |
Lymph node involvement | |||
Yes | 21 (11) | 26 (14–37) | 0.250 |
No | 60 (37) | 46 (26–66) | |
Symptoms | |||
Yes | 39 (23) | 38 (14–62) | 0.769 |
No | 42 (25) | 41 (12–71) | |
Differentiation | |||
Good | 3 (1) | 22 (–) | 0.824 |
Moderate | 37 (21) | 41 (29–54) | |
Poor | 33 (19) | 55 (32–79) | |
Size | |||
≤5 cm | 24 (14) | 57 (9–106) | 0.869 |
>5 cm | 56 (33) | 39 (20–58) | |
Cirrhosis | |||
Yes | 7 (4) | 52 (0–111) | 0.851 |
No | 72 (43) | 39 (20–58) | |
Transfusion requirement | |||
No | 56 (29) | 55 (33–78) | 0.014a |
Yes | 25 (19) | 23 (10–36) | |
Extent of vascular invasion | |||
No | 37 (21) | 57 (20–95) | 0.027 |
Microvascular | 40 (23) | 27 (8–46) | |
Macrovascular | 4 (4) | 7 (0–26) |
Significant on multivariate analysis.
Perineural invasion (P = 0.015, odds ratio 2.403, 95% CI 1−5).
Transfusion requirement (P = 0.021, odds ratio 2.134, 95% CI 1–4).
95% CI, 95% confidence interval.